Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data

• Jyotsna Batra ,

  * E-mail: jyotsna.batra@qut.edu.au

  Affiliations Australian Prostate Cancer Research Centre-Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia, Molecular Cancer Epidemiology, Queensland Institute of Medical Research, Brisbane, Queensland, Australia

  ⨯
• Felicity Lose,

  Affiliation Molecular Cancer Epidemiology, Queensland Institute of Medical Research, Brisbane, Queensland, Australia

  ⨯
• Tracy O'Mara,

  Affiliations Australian Prostate Cancer Research Centre-Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia, Molecular Cancer Epidemiology, Queensland Institute of Medical Research, Brisbane, Queensland, Australia

  ⨯
• Louise Marquart,

  Affiliation Statistics Unit, Queensland Institute of Medical Research, Brisbane, Queensland, Australia

  ⨯
• Carson Stephens,

  Affiliation Australian Prostate Cancer Research Centre-Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia

  ⨯
• Kimberly Alexander,

  Affiliation School of Nursing and Midwifery, Queensland University of Technology, Brisbane, Queensland, Australia

  ⨯
• Srilakshmi Srinivasan,

  Affiliation Australian Prostate Cancer Research Centre-Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia

  ⨯
• Rosalind A. Eeles,

  Affiliation Section of Cancer Genetics, The Institute of Cancer Research & Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London and Surrey, United Kingdom

  ⨯
• Douglas F. Easton,

  Affiliation Cancer Research UK Genetic Epidemiology Unit, Strangeways Laboratory, Cambridge, United Kingdom

  ⨯
• Ali Amin Al Olama,

  Affiliation Cancer Research UK Genetic Epidemiology Unit, Strangeways Laboratory, Cambridge, United Kingdom

  ⨯
• Zsofia Kote-Jarai,

  Affiliation Section of Cancer Genetics, The Institute of Cancer Research & Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London and Surrey, United Kingdom

  ⨯
• Michelle Guy,

  Affiliation Section of Cancer Genetics, The Institute of Cancer Research & Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London and Surrey, United Kingdom

  ⨯
• Kenneth Muir,

  Affiliation Health Sciences Research Institute, Warwick Medical School, Warwick University, Coventry, United Kingdom

  ⨯
• Artitaya Lophatananon,

  Affiliation Health Sciences Research Institute, Warwick Medical School, Warwick University, Coventry, United Kingdom

  ⨯
• Aneela A. Rahman,

  Affiliation Division of Epidemiology and Public Health, University of Nottingham, Queens Medical Centre, Nottingham, United Kingdom

  ⨯
• David E. Neal,

  Affiliation Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Freddie C. Hamdy,

  Affiliation Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Oxford, United Kingdom

  ⨯
• Jenny L. Donovan,

  Affiliation School of Social and Community Medicine, University of Bristol, Canynge Hall, Bristol, United Kingdom

  ⨯
• Suzanne Chambers,

  Affiliations Griffith Health Institute, Griffith University, Brisbane, Queensland, Australia, Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Queensland, Australia

  ⨯
• Robert A. Gardiner,

  Affiliation University of Queensland Centre for Clinical Research, Royal Brisbane Hospital, Brisbane, Queensland, Australia

  ⨯
• Joanne Aitken,

  Affiliation Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Queensland, Australia

  ⨯
• John Yaxley,

  Affiliation Brisbane Private Hospital, Brisbane, Queensland, Australia

  ⨯
• Mary-Anne Kedda,

  Affiliation Australian Prostate Cancer Research Centre-Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia

  ⨯
• Judith A. Clements ,

  Contributed equally to this work with: Judith A. Clements, Amanda B. Spurdle

  Affiliation Australian Prostate Cancer Research Centre-Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia

  ⨯
•  [ ... ],
• Amanda B. Spurdle

  Contributed equally to this work with: Judith A. Clements, Amanda B. Spurdle

  Affiliation Molecular Cancer Epidemiology, Queensland Institute of Medical Research, Brisbane, Queensland, Australia

  ⨯
• [ view all ]
• [ view less ]